PRESS RELEASE published on 12/16/2025 at 09:53, 10 months 26 days ago VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Virbac acquires innovative drug Thyronorm from Norbrook to stabilize feline hyperthyroidism, expanding distribution in key markets and enhancing senior cats' quality of life Acquisition Feline Hyperthyroidism VIRBAC Thyronorm Senior Cats
PRESS RELEASE published on 12/16/2025 at 09:53, 10 months 26 days ago VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm Virbac acquiert Thyronorm pour traiter l'hyperthyroïdie féline, améliorant la qualité de vie des chats âgés. L'acquisition renforce le portefeuille produits de Virbac Acquisition VIRBAC Hyperthyroïdie Féline Thyronorm Chats Âgés
BRIEF published on 11/07/2025 at 15:44, 1 year ago Virbac : Mise à jour sur les actions et droits de vote Euronext Paris Droits De Vote Actions Transparence VIRBAC
BRIEF published on 11/07/2025 at 15:44, 1 year ago Virbac: Update on shares and voting rights Euronext Paris Voting Rights Actions Transparency VIRBAC
PRESS RELEASE published on 11/07/2025 at 15:39, 1 year ago Virbac : Déclaration d'actions et de droits de vote 10/2025 Déclaration du nombre total d’actions et de droits de vote pour VIRBAC sur Euronext Paris. Total brut de droits de vote : 12 704 809, total net : 12 691 973 Euronext Paris Droits De Vote Santé Animale VIRBAC Total Actions
BRIEF published on 09/12/2025 at 17:50, 1 year 1 month ago Virbac Reports Solid Growth in 2025 First Half Results Revenue Growth Operating Income VIRBAC 2025 Forecast Global Market Performance
BRIEF published on 09/12/2025 at 17:50, 1 year 1 month ago Virbac annonce une croissance solide de ses résultats au premier semestre 2025 Croissance Des Revenus Résultat D'exploitation VIRBAC Prévisions Pour 2025 Performance Du Marché Mondial
PRESS RELEASE published on 09/12/2025 at 17:45, 1 year 1 month ago Virbac: 2025 Half-year results Virbac reports solid revenue growth of 5.6% in the first half of 2025, meeting adjusted operating income expectations. Targets for 2025 confirmed with revenue growth of 4-6% expected Financial Results Revenue Growth Operating Income VIRBAC Targets Confirmed
BRIEF published on 08/18/2025 at 09:35, 1 year 2 months ago Virbac dévoile la rémunération de son nouveau directeur général Directeur Général Remuneration Actions Gratuites VIRBAC Paul Martingell
BRIEF published on 08/18/2025 at 09:35, 1 year 2 months ago Virbac reveals the remuneration of its new CEO General Manager Remuneration VIRBAC Free Shares Paul Martingell
Published on 11/11/2026 at 10:30, 1 hour 31 minutes ago Temas Engages Arcstone Canada for Capital Markets Advisory and Investor-Communications Services
Published on 11/11/2026 at 03:30, 8 hours 31 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 11 hours 21 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 12 hours 31 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 13 hours 1 minute ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 11:46, 15 minutes ago ABO Energy GmbH & Co. KGaA intends to notify a Restructuring Project under the StaRUG
Published on 11/11/2026 at 11:18, 42 minutes ago Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 11/11/2026 at 11:11, 50 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA intends to notify a Restructuring Project under the StaRUG
Published on 11/11/2026 at 10:10, 1 hour 51 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 11/11/2026 at 10:00, 2 hours 1 minute ago GBC AG and Apaton Finance invite investors to the Zefiro Investor Day on November 19, 2026
Published on 11/10/2026 at 18:00, 18 hours 1 minute ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 18 hours 16 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 18 hours 26 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 18 hours 29 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
